시장보고서
상품코드
1304643

CAR-T 세포 치료 시장 : 약물 유형별, 적응증별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

CAR T-cell therapy Market with COVID-19 Impact Analysis, By Drug Type, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 288 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서의 주요 내용

CAR-T 세포 치료 시장 규모는 2022년 23억 840만 달러로 평가되었고, 2023년부터 2030년까지 연평균 복합 성장률(CAGR) 21.8%로 확대될 것입니다.

CAR-T 세포 치료 시장 - 시장 역학:

암 유병률 증가로 시장 수요 증가 전망

암의 유병률 증가는 CAR-T 세포 치료 시장의 성장을 주도할 것으로 예상됩니다. 키메라 항원 수용체 CAR-T 세포 치료는 암에 대한 면역 세포 치료의 진보적인 새로운 기둥입니다. 현재 이용 가능한 CAR-T 세포 치료는 환자별로 맞춤화되어 있습니다. 세계보건기구(WHO)에 따르면, 암은 세계 주요 사망 원인으로 2020년에는 약 1,000만 명, 즉 6명 중 1명이 암으로 사망한 것으로 추정됩니다. 미국에서만 현재 1,000명 이상의 환자가 CAR-T 세포를 투여받고 있으며, 반응 환자의 장기적인 효과를 알아보기 위한 여러 연구가 진행되고 있습니다. 새로운 생물학적 치료법에 대한 연구의 발전과 생물학적 제제공급 및 안전성 향상은 CAR-T 세포 치료 시장에 성장 기회를 제공할 것으로 예상됩니다. 생명을 위협하는 심각한 독성, 낮은 항종양 활성, 항원 회피, 수송 제한, 종양 침윤 제한 등은 시장 성장을 제한하는 요인입니다.

CAR-T 세포 치료 시장 - 주요 인사이트:

  • 우리의 연구 분석가가 공유 한 분석에 따르면, 세계 종이 봉지 포장 시장은 예측 기간(2023-2030) 동안 약 21.8%의 CAGR로 매년 성장할 것으로 예상됩니다.
  • 종이 봉지 포장 산업은 지속 가능한 성장에 대한 인식이 높아짐에 따라 빠른 속도로 성장할 것으로 예상됩니다.
  • 약물 유형별 세분화에서 티사겐 레큐셀 약물 유형은 2022년에 가장 높은 시장 점유율을 보였습니다.
  • 적응증별로는 림프종이 2022년 주요 유형으로 나타났습니다.
  • 최종 사용자별로는 2022년 주요 유형으로 호스피탈리티가 꼽혔습니다.
  • 지역별로는 북미가 2022년 주요 수익원이었습니다.

CAR-T 세포 치료 시장 - 세분화 분석 :

세계 CAR-T 세포 치료 시장은 약물 유형, 적응증, 최종 사용자 및 지역을 기준으로 세분화됩니다.

약물 유형에 따라 시장은 Ciloleucel, Tisagenlecleucel, Tisagenlecleucel, Axicabtagene, Autoleucel, Brexucabtagene 및 기타 5가지로 분류되며, Tisagenlecleucel 약물 유형이 시장을 독점하고 있습니다. 최근 승인된 제품으로는 환자의 자가 T세포를 이용한 CAR T 치료제인 티사젠레클루셀이 있는데, 이는 B세포성 급성림프모구백혈병(B-ALL) 치료제로 승인된 CAR T치료제입니다. 티쎈트릭은 현재 B-ALL의 표준 치료제로서 환자의 CAR T세포를 정확하게 모니터링할 수 있는 것이 임상적으로 매우 중요합니다.

시장은 적응증에 따라 만성 림프구성 백혈병(CLL), 다발성 골수종(MM), 림프종, 급성 림프구성 백혈병, 기타 등 6가지 카테고리로 나뉩니다. 이 치료법은 환자 자신의 T세포를 유전자 조작해 암을 공격하도록 하는 고도의 전문화된 치료법입니다.

시장은 최종 사용자별로 병원과 암 치료 센터 등 6가지 카테고리로 분류됩니다. 병원은 2022년 주요 유형입니다. 전문 암 센터와 CAR-T 세포 치료 프로그램을 갖춘 병원은 이 치료법을 시행할 수 있는 시설을 갖추고 있습니다. 이들 병원은 안전하고 효과적인 치료를 제공할 수 있는 인프라와 시설, 숙련된 의료 전문가를 갖추고 있습니다.

CAR-T 세포 치료 시장 - 지리적 통찰력 :

지리적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이 지역은 사업 운영 국가에 따라 더 세분화됩니다. 암 부담 증가와 CAR-T 세포 요법을 개발하기 위한 연구 개발 증가는 북미에서 CAR-T 세포 요법 시장의 성장을 가속할 것으로 예상됩니다. 미국 암학회에 따르면, 2021년 신규 암 환자 수와 사망자 수는 2021년 미국에서 새로 진단된 암 환자 수는 190만 명, 암 사망자 수는 60만 8,570명으로 추정됩니다. 유럽과 아시아태평양은 키메라 항원 수용체 CAR-T 세포 치료 관련 제품 승인 증가로 인해 CAR-T 세포 치료 시장의 상당한 성장을 가속할 것으로 예상됩니다.

CAR-T 세포 치료 시장 - 경쟁 구도:

각 기업은 세포주 개발 기술 강화, 신제품 개발, 새로운 치료용도 개척을 위해 연구개발에 많은 투자를 하고 있습니다. 이들 기업은 연구 위탁, 제조 위탁, 임상시험 서비스, 기타 바이오 제약 기업에 대한 지원 서비스 등 다양한 서비스를 제공합니다. 영역을 더 깊이 이해하기 위해 알락리티에 종합적인 경쟁 구도 조사를 의뢰했습니다. 이 회사는 개발 중인 주요 CAR-T 세포 치료 기업 프로파일, 이 분야의 현재 과제, 타사가 채택하고 있는 솔루션, 그리고 거래 현황을 파악하고자 했습니다. 이를 통해 자사 기술의 가치를 극대화하기 위한 사업 전략과 제품 개발 전략을 수립하는 데 도움이 될 것으로 기대했습니다.

최근 동향

2023년 5월 2일, 존슨앤드존슨의 얀센 제약회사 중 하나인 얀센파마는 B세포 악성종양 치료를 위한 차세대 키메라 항원 수용체 CAR-T 세포 치료의 개발, 제조 및 상업화와 관련하여 Cellular Cellular Biomedicine Group Inc.(CBMG)와 차세대 키메라 항원 수용체 CAR-T 세포 치료 개발, 제조 및 상업화를 위한 세계 제휴 및 라이선스 계약을 체결했다고 밝혔습니다.

조사의 주요 특징

이 보고서는 CAR-T 세포 치료 시장 시장 규모, 연평균 성장률(CAGR%), 2022년을 기준연도로 한 추정 및 예측(2023-2030년)을 제공합니다.

이 조사 보고서는 고객에게 CAR-T 세포 치료 시장에 대한 최신 동향에 대한 통찰력을 제공합니다.

조사 보고서는 다양한 부문/국가에 걸쳐 잠재적인 성장 기회를 파악하고 CAR-T 세포 치료 시장의 매력적인 투자 제안 매트릭스를 설명합니다.

이 보고서는 CAR-T 세포 치료 시장의 새로운 투자 기회, 기존 기업이 직면한 과제, 지속적인 성장 요인을 파악합니다.

COVID-19가 CAR-T 세포 치료 시장 규모, 예측, CAGR 및 시장 역학에 미치는 영향은 연구 범위에서 자세히 논의되며, COVID 이후 CAR-T 세포 치료 시장에 대한 자세한 통찰력도 다룹니다.

이 보고서는 CAR-T 세포 치료 시장에 대한 종합적인 시각을 제공하기 위해 CAR-T 세포 치료 시장 경쟁 구도와 주요 혁신기업 분석도 포함하고 있습니다.

이 보고서는 시장 규모, 성장률, 매력도를 기준으로 모든 산업 부문을 벤치마킹한 성장 전망 매핑 분석을 포함하고 있습니다.

주요 시장 진출기업의 상세한 기업 프로파일을 통해 CAR-T 세포 치료 시장에서 활동하는 기업의 재무 정보 및 전략적 이니셔티브를 이해하는 데 도움이 될 수 있습니다.

또한, 이 보고서는 세계뿐만 아니라 지역적 차원에서도 주요 시장 참여자들의 중요한 인수합병, 제휴 및 합작투자, 신제품 출시, 연구개발, 지역적 진출 등을 확인할 수 있습니다.

세계 CAR-T 세포 치료 시장 보고서는 주로 공급업체, 투자자, 신규 시장 진출기업, 유통 업체, 금융 분석가 등 이 업계의 다양한 이해 관계자를 대상으로 합니다.

목차

제1장 CAR-T 세포 치료 시장 개요

  • 조사 범위
  • 시장 추정 연수

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 CAR-T 세포 치료 주요 시장 동향

  • CAR-T 세포 치료 시장 성장 촉진요인
  • CAR-T 세포 치료 시장 성장 억제요인
  • CAR-T 세포 치료 시장 기회
  • CAR-T 세포 치료 시장 향후 동향

제4장 CAR-T 세포 치료 산업 조사

  • PEST 분석
  • Porter의 Five Forces 분석
  • 성장 전망 매핑
  • 규제 구조 분석

제5장 CAR-T 세포 치료 시장 : COVID-19의 영향 분석

  • 신형 코로나바이러스 이전의 영향 분석
  • 신형 코로나바이러스 이후의 영향 분석

제6장 CAR-T 세포 치료 시장 구도

  • CAR-T 세포 치료 시장 점유율 분석, 2022년
  • 주요 제조업체별 분석 데이터
    • 확립된 기업 분석
    • 신규 기업 분석

제7장 CAR-T 세포 치료 시장 - 약제 유형별

  • 개요
    • 약제 유형별 부문 점유율 분석
    • Axicabtagene Ciloleucel
    • Tisagenlecleucel
    • Brexucabtagene Autoleucel
    • 기타

제8장 CAR-T 세포 치료 시장 - 적응증별

  • 개요
    • 적응증별 부문 점유율 분석
    • 림프종
    • 급성 림프성 백혈병
    • 만성 림프성 백혈병(CLL)
    • 다발성 골수종(MM)
    • 기타

제9장 CAR-T 세포 치료 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원
    • 암 치료 센터

제10장 CAR-T 세포 치료 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 CAR-T 세포 치료 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 CAR-T 세포 치료 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 CAR-T 세포 치료 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 CAR-T 세포 치료 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 CAR-T 세포 치료 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - CAR-T 세포 치료 산업

  • 경쟁 대시보드
  • 기업 개요
    • Johnson &Johnson Services, Inc.
    • ALLOGENE THERAPEUTICS
    • Lonza
    • Aurora Biopharma
    • Cartesian Therapeutics, Inc.
    • Novartis
    • Bristol-Myers Squibb company
    • Gilead Sciences
    • Curocell Inc
    • JW Therapeutics

제12장 애널리스트의 다각적 견해

LSH 23.08.16

REPORT HIGHLIGHT

CAR T-cell therapy Market size was valued at USD 2,308.4 million in 2022, expanding at a CAGR of 21.8% from 2023 to 2030.

Chimeric antigen receptor (CAR)-T cell therapy has been revolutionary as it has produced remarkably effective and durable clinical responses. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy. These therapies do not require aggressive chemotherapy, and unless there is an elevation in cytokines following infusion, patients receiving CAR T-cells do not typically require immunosuppression. The advantage of chimeric antigen receptor (CAR) T-cell therapy is that it is administered in a single infusion, requiring a shorter treatment time. Also, It Improves immunogenic memory, which provides continuous surveillance to treat local and distant metastatic lesions. The main benefit of CAR-T therapy is that it can be curative for people whose blood cancer has not responded to other types of treatments. While CAR-T therapy is often considered a last resort, it is often an effective one.

CAR T-cell therapy Market- Market Dynamics:

The increasing prevalence of cancer is expected to propel market demand

The increasing prevalence of cancer is expected to dominate the growth of the CAR T-cell therapy Market. Chimeric antigen receptor (CAR)-T cell therapy is a progressive new pillar in immune cell therapy for cancer. Currently, available CAR T-cell therapies are customized for each individual patient. According to World health organization, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In the United States alone, well over 1000 patients have now received CAR-T cells, and several studies have opened looking at the long-term effects in responders. Advancing research on novel biotherapies and increasing the supply and safety of biologics are the factors that are expected to provide growth opportunities for the CAR T-cell therapy market. The severe life-threatening toxicities, modest anti-tumor activity, antigen escape, restricted trafficking, and limited tumor infiltration are the factors which restrict the growth of market.

CAR T-cell Therapy Market- Key Insights:

  • As per the analysis shared by our research analyst, the global CAR T-cell therapy market is estimated to grow annually at a CAGR of around 21.8% over the forecast period (2023-2030)
  • Based on Drug Type segmentation, Tisagenlecleucel drug type was predicted to show maximum market share in the year 2022
  • Based on Indication segmentation, Lymphoma was the leading type in 2022
  • Based on End-User segmentation, Hospitals was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

CAR T-cell Therapy Market- Segmentation Analysis:

The Global CAR T-cell therapy Market is segmented on the basis of Drug Type, Indication, End User, and Region.

The market is divided into five categories based on Drug Type: Ciloleucel, Tisagenlecleucel, Axicabtagene, Autoleucel, Brexucabtagene, and Others. Tisagenlecleucel drug type dominates the market. One such recently licensed product has been Tisagenlecleucel, a CAR T therapy approved for the treatment of B-cell acute lymphoblastic leukemia (B-ALL) using autologous T cells from the patient. Since Tisagenlecleucel is now a standard of care treatment for B-ALL, it is clinically essential to be able to accurately monitor these CAR T cells in patients.

The market is divided into six categories based on Indication: Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Lymphoma, Acute Lymphocytic Leukemia, and Others. dominates the market and is likely to maintain its dominance during the forecast period. It is a highly specialized therapy that involves genetically modifying a patient's own T cells to attack their cancer.

The market is divided into six categories based on End -User: Hospitals and Cancer Treatment Centers. Hospitals are the leading type in 2022. Hospitals with specialized cancer centers or designated CAR T-cell therapy programs are equipped to handle the administration of this therapy. They have the infrastructure, facilities and experienced health professionals to provide safe and effective treatment.

CAR T-cell therapy Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The increasing burden of cancer and the rise in research and development to develop CAR T-cell therapy is expected to drive the growth of CAR T-cell therapy Market in north America. According to the American cancer society, number of new cancer cases and deaths in 2021 (In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States. Europe and Asia Pacific are expected to propel significant growth in CAR T-cell therapy Market, due to the Growing Product Approvals Associated with Chimeric antigen receptor (CAR)-T cell therapy.

CAR T-cell therapy Market- Competitive Landscape:

Companies invest heavily in research and development to enhance their cell line development technologies, develop new products, and explore novel therapeutic applications. These players offer a wide range of services, including contract research, contract manufacturing, clinical trial services, and other support services for biopharmaceutical companies. A biotech company developing a platform technology to improve the safety of CAR T-cell therapies asked Alacrity to conduct a comprehensive competitive landscape to better understand the current CAR T-cell therapy space. The company wanted to understand the product profiles of top CAR T-cell therapies in development, current challenges in the field and solutions other companies are employing, as well as the deals landscape. This would help guide their business and product development strategy to maximize the value of their technology.

Recent Developments:

In May 2, 2023 -one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced nowadays that it has entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc. (CBMG) to develop, manufacture and commercialize next-generation chimeric antigen receptor (CAR) T-cell therapies for the treatment of B-cell malignancies.

Key features of the study:

This proposed research study on CAR T-cell therapy market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The report provides the client the latest up-to-date and trending insights about the CAR T-cell therapy market.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for CAR T-cell therapy market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the CAR T-cell therapy market

Impact of COVID-19 on CAR T-cell therapy market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on CAR T-cell therapy market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the CAR T-cell therapy market, we have also included competitive landscape and key innovator analysis for the CAR T-cell therapy market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the CAR T-cell therapy market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global CAR T-cell therapy market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CAR T-CELL THERAPY MARKET KEY PLAYERS

  • Johnson & Johnson Services, Inc.
  • ALLOGENE THERAPEUTICS
  • Lonza
  • Aurora Biopharma
  • Cartesian Therapeutics, Inc.
  • Novartis
  • Bristol-Myers Squibb company
  • Gilead Sciences
  • Curocell Inc
  • JW Therapeutics

GLOBAL CAR T-CELL THERAPY MARKET, BY DRUG TYPE

  • Axicabtagene Ciloleucel
  • Tisagenlecleucel
  • Brexucabtagene Autoleucel
  • Others

GLOBAL CAR T-CELL THERAPY MARKET, BY INDICATION

  • Lymphoma
  • Acute Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Multiple Myeloma (MM)
  • Others

GLOBAL CAR T-CELL THERAPY MARKET, BY END-USER

  • Hospitals
  • Cancer Treatment Centers

GLOBAL CAR T-CELL THERAPY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. CAR T-Cell Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CAR T-Cell Therapy Market Snippet by Drug Type
    • 2.1.2. CAR T-Cell Therapy Market Snippet by Indication
    • 2.1.3. CAR T-Cell Therapy Market Snippet by End User
    • 2.1.4. CAR T-Cell Therapy Market Snippet by Country
    • 2.1.5. CAR T-Cell Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. CAR T-Cell Therapy Key Market Trends

  • 3.1. CAR T-Cell Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CAR T-Cell Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CAR T-Cell Therapy Market Opportunities
  • 3.4. CAR T-Cell Therapy Market Future Trends

4. CAR T-Cell Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CAR T-Cell Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. CAR T-Cell Therapy Market Landscape

  • 6.1. CAR T-Cell Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CAR T-Cell Therapy Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
    • 7.1.2. Axicabtagene Ciloleucel
    • 7.1.3. Tisagenlecleucel
    • 7.1.4. Brexucabtagene Autoleucel
    • 7.1.5. Others

8. CAR T-Cell Therapy Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 8.1.2. Lymphoma
    • 8.1.3. Acute Lymphocytic Leukemia
    • 8.1.4. Chronic Lymphocytic Leukemia (CLL)
    • 8.1.5. Multiple Myeloma (MM)
    • 8.1.6. Others

9. CAR T-Cell Therapy Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Cancer Treatment Centers

10. CAR T-Cell Therapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. CAR T-Cell Therapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. CAR T-Cell Therapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. CAR T-Cell Therapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. CAR T-Cell Therapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. CAR T-Cell Therapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- CAR T-Cell Therapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
    • 11.2.2. ALLOGENE THERAPEUTICS
    • 11.2.3. Lonza
    • 11.2.4. Aurora Biopharma
    • 11.2.5. Cartesian Therapeutics, Inc.
    • 11.2.6. Novartis
    • 11.2.7. Bristol-Myers Squibb company
    • 11.2.8. Gilead Sciences
    • 11.2.9. Curocell Inc
    • 11.2.10. JW Therapeutics

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제